Drug distribution: Council urges stakeholders to comply with guidelines

UKRAINE - 2019/07/19: In this photo illustration, A closeup view of Glucosamine Chondrotin pills. (Photo Illustration by Igor Golovniov/SOPA Images/LightRocket via Getty Images)

The Registrar, Pharmacists Council of Nigeria (PCN), Elijah Mohammed has advised stakeholders in the Nigeria’s drug distribution system to comply with the National Drug Distribution Guidelines (NDDG).

Mohammed, in a statement, said that the major obstacle in maintaining quality, safe and efficacious medicines in the country, was the chaotic drug distribution system.

He particular decried operation of the open drug market, saying it was the major contributor to the challenges.

“Also, poor storage facilities which expose the medicines to harsh environmental factors impact negatively on the drugs.

Sale of ethical medicines without the supervision of pharmacists, proliferation of unregistered premises, encouragement of illegal sale, abuse and misuse of controlled medicines, are all contributing.’’

The registrar said to curb the trend, PCN had encouraged stakeholders in the open market to move into Coordinated Wholesale Centres (CWCs), as specified in the guidelines.

He also said that PCN had developed a check-list for CWCs to guide implementation.

He said some private sector operators who had shown interest in establishing mega wholesale centers, applied for inspection of their premises; and some had been approved by the council.

According to him, while some states are working on their project, others are upgrading their medical stores to meet the requirements for Public Wholesale Centres.

“Constructions are still ongoing in some places, but some states have not shown enough enthusiasm.”

He, however, commended the commitment of some states like Ebonyi, which had pledged to ensure the construction of a CWC to accommodate all medicine dealers operating in open drug markets in the state.

Mohammed had given the deadline for medicine dealers in the open market to move to CWCs, as Dec. 31, 2018.

The registrar embarked on advocacy visits to states where open drug markets were located, to solicit the cooperation of the governments in moving them to CWCs.